Dow Up0.09% Nasdaq Down0.02%




News & Info


Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates


  • Major Holders
  • Insider Transactions
  • Insider Roster


AstraZeneca Pharma India Limited (ASTRAZEN.NS)

978.50 Down 2.05(0.21%) 6:00AM EDT
ProfileGet Profile for:
AstraZeneca Pharma India Limited
Post box No. 2483
Bengaluru, 560024
India - Map
Phone: 91 80 6774 8000
Fax: 91 80 2362 2015

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

AstraZeneca Pharma India Limited engages in the manufacture, distribution, and marketing of pharmaceutical products in India and internationally. It operates in three segments: Healthcare, Clinical Trial Services, and Co-promotional Services. The company primarily provides products in the areas of cardiovascular, gastrointestinal, infection, neuroscience, oncology, and respiratory and inflammation healthcare. Its products include Betaloc, Seloken XL, Imdur, Crestor, Seloram, Vigocil, Vigocil M, Nitract SR, Valfect,Olways, Olways H, Olways AM for cardiovascular diseases; and Onglyza, Kombiglyze XR, and Byetta for diabetes. The company also offers Mit’s Linctus Codeinae Co, Mit’s Linctus DX, Bricarex, Bricarex A, Bricacef, Bricacef PED, Bricanyl Syrup, and Symbicort for respiratory diseases; Prostodin, Cerviprime, and Partocin for maternal healthcare; Arimidex, Nolvadex, Iressa, Zoladex, Casodex, and Faslodex for oncology; and Meronem, Vancocin CP, Enclere, and Remergin for infections. In addition, it provides Xylocaine, Sensorcaine, Diprivan, and Naropin for neuroscience; and Neksium tablets and injections for gastrointestinal diseases. The company was incorporated in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on AstraZeneca Pharma India Limited

Key Executives 
Ms. Ruby Lau , 43
VP of Operations
Mr. Robert Ian Haxton , 45
Whole-Time Director and Member of Share Transfer Committee
Mr. Sanjay Murdeshwar , 48
Managing Director, Director, Member of Share Transfer Committee and Member of Shareholders'/Investors' Grievance Committee
Mr. Rajesh Marwaha , 51
Chief Financial Officer
Mr. Ramesh Kadaba Venkatapathi , 62
Director of Quality Assurance & Technical Services
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.